BioInfoBank Library


FP7 Partner
Add BioInfo.PL bioinformatics lab to Your FP7 application
username:
password:
Forgot password
Register
Login
Submit a short report and win 100 €
author name recommending commenting favorite    papers recom. cited
0 0 0 29 0 5 [Update]
0 0 0 1 0 0 [Update]
0 0 0 1 0 0 [Update]
0 0 0 17 0 124 [Update]
0 0 0 1 0 9 [Update]
0 0 0 1 0 0 [Update]
0 0 0 2 0 0 [Update]
0 0 0 1 0 3 [Update]
0 0 0 3 0 0 [Update]
0 0 0 4 0 0 [Update]

Latest Paper:

Fish Shellfish Immunol. 2009 Nov 13;: 19922799 (P,S,G,E,B,D)
Central Institute of Freshwater Aquaculture, Kausalyaganga, Bhubaneswar-751002, India.
Immunogenicity in of different antigen preparations of outer membrane protein (OMP) of Aeromonas hydrophila such as Poly D, L-lactide-co-glycolic acid (PLGA) microparticles,antigen oil emulsion, neat OMP and bacterial whole cells were compared through intra-peritoneal injection in fish, Labeo rohita. Among these preparations,Labeo PLGA encapsulated antigen stimulated both innate and adaptive immune parameters and the immunogenicity exhibited by PLGA microparticles was significantly higher delivery (p< .05) at both 21 and 42 days post-immunization suggesting that the above delivery system would be a novel antigen D, carrier for parenteral immunization in fish, Labeo rohita.
Nanomed. 2009 Oct ;4 (7):773-85 19839813 (P,S,G,E,B,D)
Laboratory for Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India. sanjeebsahoo2005@gmail.com.
Aim:was In the development of controlled-release protein therapeutics, the high encapsulation of proteins into biodegradable nanoparticles with uniform size in an encapsulation anhydrous process along with an excellent redispersion is of practical interest. The objective of this work was to study the were physicochemical and in vitro release properties of chitosan nanoparticles with different molecular weights (low, medium and high) using bovine serum the albumin (BSA) as a model protein for developing nanoparticle formulations that were stable and reproducible after lyophilization. Materials & methods:weights The BSA-loaded chitosan nanoparticles were prepared by an ionic gelation method using pentasodium tripolyphosphate as the polyanions. The physicochemical properties The and in vitro release kinetics of the nanoparticles were evaluated along with Fourier transform infrared spectroscopy studies. Furthermore, the nanoparticles no were freeze-dried for long-term stability in the formulation. To optimize the size of the freeze-dried nanoparticles after redispersion, various types for of lyoprotectants (natural and synthetic) were tested in varying concentration in the process of lyophilization. Results: The dynamic light scattering nanoparticles. measurements revealed the increase in size of chitosan nanoparticles with the increase in molecular weight of chitosan with no significant therapeutics, change, irrespective of the concentration of BSA entrapped. In addition, the entrapment efficiency of the nanoparticles increased with the increasing types molecular weight of chitosan and BSA concentration. By contrast, the redispersity of the freeze-dried samples resulted in further increase of sucrose, the mean diameter of the nanoparticles. Conclusion: Among the various types of lyoprotectants (natural and synthetic) examined, sucrose proved to proteins be very effective in reducing the size of freeze-dried nanoparticles on redispersion without significant change in surface charge of nanoparticles.was Finally, the in vitro release kinetics of BSA from nanoparticles of different molecular weights of chitosan, with and without sucrose,sucrose was evaluated and found to depend upon the molecular weight of chitosan.
J Biol Chem. 2009 Sep 9;: 19740751 (P,S,G,E,B,D)
Gwangju Institute of Science and Technology, Korea, Republic of.
Calumenin its is a multiple EF-hand Ca(2+) binding protein localized in the sarcoplasmic reticulum (SR) with C-terminal SR retention signal HDEF. Recently,localized we showed evidence that calumenin interacts with SERCA2 in rat cardiac SR (1). The present study was undertaken to showed further characterize the association of calumenin with SERCA2 in mouse heart by various gene manipulation approaches. Immunocytochemical analysis showed that of calumenin and SERCA2 were partially co-localized in HL-1 cells. Knockdown (KD) of calumenin was conducted in HL-1 cells and 80%association reduction of calumenin did not induce any expressional changes of other Ca(2+)-cycling proteins. But it enhanced Ca(2+) transient amplitude and SERCA2 showed shortened time to reach peak and decreased time to reach 50% of baseline. Oxalate-supported Ca(2+) uptake showed increased Ca(2+)Ca(2+), sensitivity of SERCA2 in calumenin KD HL-1 cells. Calumenin and SERCA2 interaction was significantly lower in the presence of thapsigargin,shortened vanadate or ATP, as compared with 1.3 microM Ca(2+), suggesting that the interaction is favored in E1 state of SERCA2.binding GST-pull down assay of calumenin deletion fragments and SERCA2 luminal domains suggested that 132-222 amino acids region of calumenin and binding SERCA2-L4 (853-892 amino acids) are the major binding partners. On the basis of our in vitro binding data and available uptake information on 3D structure of Ca(2+)-ATPases, a molecular model was proposed for the interaction between calumenin and SERCA2. Taken together,and the present results suggest that calumenin is a novel regulator of SERCA2 and its expressional changes are tightly coupled with the Ca(2+)-cycling of cardiomyocytes.
Org Lett. 2009 Sep 8;: 19736914 (P,S,G,E,B,D)
Department of Chemistry, Indian Institution of Technology Guwahati, Guwahati 781 039, India.
We synthesis have for the first time developed two ligand-assisted Cu(I)-catalyzed sequential intra- and intermolecular S-arylations leading to the direct synthesis of for arylthiobenzothiazoles in one pot without an inert atmosphere. Low catalyst loading, inexpensive metal catalyst and ligand, lower reaction temperature, and one shorter reaction times make this method superior to all reported methods for the synthesis of arylthiobenzothiazole.
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Jul 8;: 19713149 (P,S,G,E,B,D)
Department of Chemistry, Sant Longowal Institute of Engineering & Technology (Deemed to-be University), Longowal 148106, Punjab, India.
Two force novel tripodal imine-phenol ligands, cis,cis-1,3,5-tris{(2-hydroxybenzilidene)aminomethyl}cyclohexane (TMACHSAL, L(1)) and of cis,cis-1,3,5-tris{[(2-hydroxyphenyl)ethylidene]aminomethyl}cyclohexane (Me(3)-TMACHSAL, L(2)) have been synthesized and characterized by elemental analyses (TMACHSAL, and various spectral (UV-vis, IR and (1)H and (13)C NMR) data. The complexation reactions of the ligands with H(+) and L(1) Fe(III) were investigated by potentiometric and spectrophotometric methods at an ionic strength of .1M KCl and 25+/-1 degrees C in than aqueous medium. Three protonation constants each for ligands L(1) and L(2) were determined and were used as input data to NMR) evaluate the formation constants of the metal complexes. Formations of metal complexes of the types FeLH(3), FeLH(2), FeLH, FeL and metal FeLH(-1) were depicted in solution. Experimental evidences suggested for a formation of tris(iminophenolate) type metal complex by the ligands. The depicted ligand L(1) showed higher affinity towards iron(III) than L(2). The pFe value related to L(1)(pFe=20.14) is approximately four units and higher than L(2)(pFe=16.41) at pH=7.4. The structures of the metal complexes were proposed through the molecular mechanics calculation using The MM3 force field followed by semi-empirical PM3 method.
Biomaterials. 2009 Jul 22;: 19631377 (P,S,G,E,B,D)
Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India.
Selective carrier drug delivery is an important approach with great potential for overcoming problems associated with the systemic toxicity and poor bioavailability great of antineoplastic drugs. Nanomedicine plays a pivotal role by delivering drugs in a targeted manner to the malignant tumor cells linking thereby reducing the systemic toxicity of the anticancer drugs. The objective of this study was to prepare and characterize rapamycin protein loaded polymeric poly(lactide-co-glycolide)(PLGA) nanoparticles (NP) that were surface conjugated with antibodies to epidermal growth factor receptor (EGFR), highly expressed reducing on breast cancer cells, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) mediated cross linking agents. To potentiate the anticancer on efficiency of the formulations, in vitro cytotoxicity of native rapamycin, rapamycin loaded nanoparticles and EGFR antibody conjugated rapamycin loaded nanoparticles showed (EGFR-Rapa-NPs) were evaluated on malignant MCF 7 breast cancer cell lines. IC(50) doses as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay To showed the superior antiproliferative activity of EGFR-Rapa-NPs over unconjugated nanoparticles and native rapamycin due to higher cellular uptake on malignant flow breast cancer cells. Cell cycle arrest and cellular apoptosis induced by the above formulations were confirmed by flow cytometry. Molecular important basis of apoptosis studied by western blotting revealed the involvement of a cytoplasmic protein in activating the programmed cell death rapamycin, pathway. Thus it was concluded that EGFR-Rapa-NPs provide an efficient and targeted delivery of anticancer drugs, presenting a promising active targeting targeting carrier for tumor selective therapeutic treatment in near future.
Org Lett. 2009 Jul 16;: 19606819 (P,S,G,E,B,D)
Department of Chemistry, Indian Institution of Technology Guwahati, Guwahati 781 039, India.
An related unprecedented transfer of a thiocyanate (-SCN) group from aroyl/acyl isothiocyanate to alkyl or benzylic bromide is observed in the presence unprecedented of a tertiary amine. This process is most effective when the bromomethyl proton is less acidic, while the presence of of a more acidic proton gives 1,3-oxathiol-2-ylidine and other related products.
Nanomed. 2009 Jul ;4 (5):519-530 19572818 (P,S,G,E,B,D)
Laboratory for Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India. sanjeebsahoo2005@gmail.com.
Aim:of To increase the entrapment efficiency of doxycycline (DXY)-loaded poly(D,L-lactide-co-glycolide)(PLGA):poly(epsilon-caprolactone)(PCL) nanoparticles by up to 70% by varying the different doxycycline formulation parameters such as polymer ratio, amount of drug loading (w/w), solvent selection, electrolyte addition and pH in the formulation.analysis Method: Biodegradable polymers PLGA and PCL are used in various ratios for nanoparticle preparation using the water-in-oil-in-water double emulsion technique Escherichia for water-soluble DXY. The physicochemical characterization of nanoparticles included size and surface charge measurement, study of surface morphology using scanning-electron formulation. microscopy, Fourier transform infrared spectroscopy study, differential scanning calorimetry analysis and in vitro release kinetics study. Results: The mean particle microscopy size ranged from 230 to 360 nm, as measured by dynamic laser light scattering, and scanning-electron microscopy confirmed the spherical void nature and smooth surface of the nanoparticles. Fourier transform infrared spectroscopy analysis of void nanoparticles, drug-loaded nanoparticles and native DXY and indicated no interaction between the drug and polymer in the nanoparticle. Differential scanning calorimetry analysis of drug-loaded nanoparticles indicated a The molecular level dispersion of DXY in the formulation. The antibacterial activity of native DXY and DXY-loaded nanoparticles were tested using efficiency a strain of Escherichia coli (DH5alpha) through growth inhibition and colony-counting method. The results indicated that DXY-loaded nanoparticles are more to effective than native DXY due to the sustained release of DXY from nanoparticles in the E. coli strain.
Int J Mol Sci. 2009 Mar ;10 (3):1215-25 19399245 (P,S,G,E,B,D)
Health Technology Research Center, National Institute of Advanced Industrial Science and Technology (AIST), West, Tsukuba, Ibaraki 305-8569, Japan; E-Mails: rjunko@nifty.com (J.S.); y-masuo@aist.go.jp (Y.M.).
We ultra report molecular changes in leaves of rice plants (Oryza sativa L.- reference crop plant and grass model) exposed to changes ultra low-dose ionizing radiation, first using contaminated soil from the exclusion zone around Chernobyl reactor site. Results revealed induction of marker stress-related marker genes (Northern blot) and secondary metabolites (LC-MS/MS) in irradiated leaf segments over appropriate control. Second, employing the same genes in vitro model system, we replicated results of the first experiment using in-house fabricated sources of ultra low-dose gamma (gamma)model) rays and selected marker genes by RT-PCR. Results suggest the usefulness of the rice model in studying ultra low-dose radiation over response/s.
Expert Opin Drug Deliv. 2009 Mar ;6 (3):285-304 19327045 (P,S,G,E,B)
Laboratory for Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India +91 674 230 2094 ;+91 674 230 0728 ; sanjeebsahoo2005@gmail.com.
Background:a Limited accessibility of drugs to the tumor tissues, the requirement of high doses, intolerable cytotoxicity, the development of multiple drug the resistance and non-specific targeting are obstacles to the clinical use of cancer drugs and cancer therapy. Objective: Drug delivery through therapy. carrier systems to cancerous tissue is no longer simply wrapping up cancer drugs in a new formulation for different routes will of delivery, rather the focus is on targeted cancer therapy. Methods: This review summarizes the exploitation of drug-loaded nanocarrier conjugates of with various targeting moieties for the delivery and targeting of anticancer drugs and describes the current status of and challenges drugs in the field of nanocarrier-aided drug delivery and drug targeting. Conclusion: The discovery of targeting ligand to cancer cells and of the development of ligand-targeted therapy will help us to improve therapeutic efficacy and reduce side effects. Unlike other forms of Methods: therapy, it will allow us to maintain quality of life for patients, while efficiently attacking the cancer tissue. It indicates efficacy that ligands have a pivotal role in cancer cell targeting.
Science news